M4565
Matrix Metalloproteinase-7 human
~0.1 mg/mL, recombinant, expressed in E. coli, buffered aqueous solution
Sinónimos:
MMP-7, Matrilysin-1
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
| Tamaño de envase | SKU | Disponibilidad | Precio |
|---|---|---|---|
| 10 μg | Comprobar disponibilidad del carrito | MXP 13,370.00 |
Acerca de este artículo
Specific activity:
5,000 units/mg protein
Recombinant:
expressed in E. coli
Concentration:
~0.1 mg/mL
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarlerecombinant
expressed in E. coli
Quality Level
form
buffered aqueous solution
specific activity
5,000 units/mg protein
mol wt
20 kDa
concentration
~0.1 mg/mL
UniProt accession no.
relevant disease(s)
cancer
shipped in
dry ice
storage temp.
−70°C
Gene Information
human ... MMP7(4316)
General description
Matrix metalloproteinase-7 (MMP7) also referred to as matrilysin is encoded by the gene mapped to human chromosome 11q21-q22. MMP7 is a smallest member of MMP enzyme family and is highly expressed in cancer cells. MMP7 is exclusively released by epithelial cells.[1]
Application
Matrix metalloproteinase-7 (MMP7) human has been used in in silico analysis of MMP-7 proteolysis of perlecan.[2]
Biochem/physiol Actions
Matrix metalloproteinase-7 (MMP-7) catalyzes the cleavage of extracellular matrix (ECM) proteins such as proteoglycans, fibronectin, entactin, laminin, collagen III/ IV/ V/ IX/ X/ XI, type I/ II/ IV/ V gelatins, and elastin.[1] Matrix metalloproteinase-7 facilitates initial stages of tumor progression. Activated MMP7 plays a vital role in human colorectal cancer (CRC) liver metastases. Overexpression of MMP7 is observed in various human cancers, such as breast, lung, prostate, esophagus, stomach, endometrium, and ovarian carcinomas, as well as esophageal squamous cell carcinomas. Increased expression of MMP7 is also associated with pathogenesis of demyelinating multiple sclerosis (MS) lesions. Both in silico and in vitro studies show that MMP7 degrades glycosylated and basement membrane bound perlecan and plays a vital role in prostate cancer cell invasion.[2]
Physical form
Solution in 10 mM HEPES, 5 mM CaCl2, 150 mM NaCl
Analysis Note
One unit of enzyme activity is defined as the digestion of 1 μg of azocoll/min. at pH 7.5 and 37 °C.
1 of 1
Este artículo | |||
|---|---|---|---|
| Gene Information human ... MMP7(4316) | Gene Information human ... MMP7(4316) | Gene Information human ... MMP1(4312) | Gene Information human ... MMP9(4318) |
| specific activity 5,000 units/mg protein | specific activity - | specific activity - | specific activity - |
| recombinant expressed in E. coli | recombinant - | recombinant expressed in NSO cells | recombinant - |
| concentration ~0.1 mg/mL | concentration ~1 mg/mL | concentration - | concentration - |
| form buffered aqueous solution | form buffered aqueous solution | form buffered aqueous solution | form buffered aqueous solution |
| shipped in dry ice | shipped in wet ice | shipped in dry ice | shipped in dry ice |
flash_point_f
Not applicable
flash_point_c
Not applicable
wgk
WGK 1
Clase de almacenamiento
12 - Non Combustible Liquids
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior.
Grindel BJ, et.al.
Matrix Biology, 36, 64-76 (2014)
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.
Cossins JA
Acta Neuropathologica, 94(6), 590-598 (1997)
Matrilysin.
Wilson, C.L. et al.
Matrix Metalloproteinases, 149-149 (1998)
Número de artículo de comercio global
| SKU | GTIN |
|---|---|
| M4565-10UG | 04061833219577 |